MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-196 Cr | ₹-12,683 Cr | ₹-2,082 Cr | ₹-1,054 Cr | ₹-1,369 Cr |
What is the latest Cash Flow from Investing Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-196 Cr |
| Mar2025 | ₹-12,683 Cr |
| Mar2024 | ₹-2,082 Cr |
| Mar2023 | ₹-1,054 Cr |
| Mar2022 | ₹-1,369 Cr |
How is Cash Flow from Investing Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-196 Cr | Negative | |
| Mar2025 | ₹-12,683 Cr | Negative | |
| Mar2024 | ₹-2,082 Cr | Negative | |
| Mar2023 | ₹-1,054 Cr | Negative | |
| Mar2022 | ₹-1,369 Cr | - | |
Compare Cash Flow from Investing Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹95,733.4 Cr | 1.8% | -3.1% | -11% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.8% |
-3.1% |
-11% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses